A protocol for a randomised, double-blind, placebo-controlled study of the effect of LIraglutide on left VEntricular function in chronic heart failure patients with and without type 2 diabetes (The LIVE Study)

INTRODUCTION: Heart failure is one of the most common cardiovascular complications of diabetes and the most disabling and deadly complication too. Many antidiabetic agents have been associated with increased morbidity and mortality in a subset of patients with chronic heart failure (CHF); thus, new...

Descripción completa

Detalles Bibliográficos
Autores principales: Jorsal, Anders, Wiggers, Henrik, Holmager, Pernille, Nilsson, Brian, Nielsen, Roni, Boesgaard, Trine Welløv, Kumme, Anja, Møller, Jacob Eifer, Videbæk, Lars, Kistorp, Caroline, Gustafsson, Ida, Tarnow, Lise, Flyvbjerg, Allan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4039804/
https://www.ncbi.nlm.nih.gov/pubmed/24844271
http://dx.doi.org/10.1136/bmjopen-2014-004885

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4039804/
https://www.ncbi.nlm.nih.gov/pubmed/24844271
http://dx.doi.org/10.1136/bmjopen-2014-004885

Ejemplares similares